drugset / Trial / NCT00718913
Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer
Phase 2
Completed
40 enrolled
Hellenic Oncology Research Group
University Hospital of Crete · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will determine the feasibility of adjuvant chemotherapy and chemo-radiotherapy for patients with surgically resected adenocarcinoma of the stomach and gastro-esophageal junction.
Timeline
- Start
- 2008-04
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1650 mg/m2 | Oral |
| Subject | Capecitabine | Small molecule | 1800 mg/m2 | Oral |
| Subject | Cisplatin | Other / unclassified | 60 mg/m2 | Intravenous |
| Subject | Docetaxel | Small molecule | 60 mg/m2 | Intravenous |